397 related articles for article (PubMed ID: 36030128)
1. Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses' infections.
Ghrieb Z; Salmona M; Michonneau D; De Saisset C; Allaoua S; Kiladjian JJ; Le Goff J; Bergeron A; Benajiba L
Therapie; 2023; 78(3):241-245. PubMed ID: 36030128
[TBL] [Abstract][Full Text] [Related]
2. Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study.
Boehm AB; Hughes B; Duong D; Chan-Herur V; Buchman A; Wolfe MK; White BJ
Lancet Microbe; 2023 May; 4(5):e340-e348. PubMed ID: 36965504
[TBL] [Abstract][Full Text] [Related]
3. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
4. Collateral Impact of Public Health and Social Measures on Respiratory Virus Activity during the COVID-19 Pandemic 2020-2021.
Achangwa C; Park H; Ryu S; Lee MS
Viruses; 2022 May; 14(5):. PubMed ID: 35632810
[TBL] [Abstract][Full Text] [Related]
5. Impact of the SARS-CoV-2 pandemic on the overall respiratory viruses' transmission in a cancer care setting.
Mubarak S; Alsmadi O; Tbakhi A; Ata OA; Hassan A; AlGhawrie H
Immun Inflamm Dis; 2023 Nov; 11(11):e1073. PubMed ID: 38018583
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of respiratory virus transmission before and during the COVID-19 pandemic in Pune the western region of India.
Bhardwaj S; Choudhary ML; Jadhav S; Vipat V; Ghuge R; Salvi S; Kulkarni R; Kinikar A; Padbidri V; Bafna S; Bavdekare A; D'costa P; Gujar N; Potdar V
Front Public Health; 2022; 10():936634. PubMed ID: 36159243
[TBL] [Abstract][Full Text] [Related]
7. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.
Yuen E; Gudis DA; Rowan NR; Nguyen SA; Schlosser RJ
Am J Rhinol Allergy; 2021 Jan; 35(1):122-131. PubMed ID: 32762250
[TBL] [Abstract][Full Text] [Related]
8. Viral co-infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID-19 pandemic in Yaoundé, Cameroon, 2020-2021.
Moumbeket Yifomnjou MH; Monamele GC; Njankouo-Ripa M; Fatawou Modiyinji A; Ngoupo PA; Boyomo O; Njouom R
Influenza Other Respir Viruses; 2023 Mar; 17(3):e13131. PubMed ID: 36991539
[TBL] [Abstract][Full Text] [Related]
9. Circulation of Respiratory Viruses in Hospitalized Adults before and during the COVID-19 Pandemic in Brescia, Italy: A Retrospective Study.
De Francesco MA; Pollara C; Gargiulo F; Giacomelli M; Caruso A
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574450
[TBL] [Abstract][Full Text] [Related]
10. The epidemiological features of pediatric viral respiratory infection during the COVID-19 pandemic in Taiwan.
Hsu HT; Huang FL; Ting PJ; Chang CC; Chen PY
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):1101-1107. PubMed ID: 34756671
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological characteristics of respiratory viruses in hospitalized children during the COVID-19 pandemic in southwestern China.
Zhu L; Luo T; Yuan Y; Yang S; Niu C; Gong T; Wang X; Xie X; Luo J; Liu E; Fu Z; Tian D
Front Cell Infect Microbiol; 2023; 13():1142199. PubMed ID: 37153160
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19.
Luo J; Zhang Z; Zhao S; Gao R
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047339
[TBL] [Abstract][Full Text] [Related]
13. Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea.
Yum S; Hong K; Sohn S; Kim J; Chun BC
Emerg Infect Dis; 2021; 27(6):1685-1688. PubMed ID: 34013875
[TBL] [Abstract][Full Text] [Related]
14. The effects of the COVID-19 pandemic on community respiratory virus activity.
Chow EJ; Uyeki TM; Chu HY
Nat Rev Microbiol; 2023 Mar; 21(3):195-210. PubMed ID: 36253478
[TBL] [Abstract][Full Text] [Related]
15. Respiratory viral infections in the immunocompromised.
Ison MG
Curr Opin Pulm Med; 2022 May; 28(3):205-210. PubMed ID: 35102093
[TBL] [Abstract][Full Text] [Related]
16. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the Respiratory Viral Panel PCR Test Results Before and After COVID-19 Pandemic].
Alp A; Taşçı O; Ergin A; Köseoğlu Eser Ö
Mikrobiyol Bul; 2022 Oct; 56(4):667-681. PubMed ID: 36458713
[TBL] [Abstract][Full Text] [Related]
18. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
[TBL] [Abstract][Full Text] [Related]
19. Changes in virus detection in hospitalized children before and after the severe acute respiratory syndrome coronavirus 2 pandemic.
Kume Y; Hashimoto K; Chishiki M; Norito S; Suwa R; Ono T; Mochizuki I; Mashiyama F; Ishibashi N; Suzuki S; Sakuma H; Takahashi H; Takeda M; Shirato K; Hosoya M
Influenza Other Respir Viruses; 2022 Sep; 16(5):837-841. PubMed ID: 35488324
[TBL] [Abstract][Full Text] [Related]
20. Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic.
Agca H; Akalin H; Saglik I; Hacimustafaoglu M; Celebi S; Ener B
J Infect Public Health; 2021 Sep; 14(9):1186-1190. PubMed ID: 34399190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
